Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Colorcon
Fish and Richardson
Johnson and Johnson
Julphar
Chubb
Mallinckrodt
Moodys

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020742

« Back to Dashboard

NDA 020742 describes BSS, which is a drug marketed by Alcon and is included in two NDAs. It is available from one supplier. Additional details are available on the BSS profile page.

The generic ingredient in BSS is calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate. There are two hundred and seventy-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate profile page.
Summary for 020742
Suppliers and Packaging for NDA: 020742
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BSS calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate SOLUTION;IRRIGATION 020742 NDA Alcon Laboratories, Inc. 0065-0795 N 0065-0795-15
BSS calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate SOLUTION;IRRIGATION 020742 NDA Alcon Laboratories, Inc. 0065-0795 N 0065-0795-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IRRIGATIONStrength0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6.4MG/ML;1.7MG/ML
Approval Date:Dec 10, 1997TE:ATRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Federal Trade Commission
Baxter
Daiichi Sankyo
Citi
US Department of Justice
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.